Oncology & Cancer

PSA screening tied to lower risk of prostate cancer mortality

Prostate-specific antigen (PSA) screening is associated with decreased risk of prostate cancer-specific mortality (PCSM) among both Black and White men, according to a study published online Aug. 4 in JAMA Oncology.

Oncology & Cancer

Portable prostate cancer test may help reach underserved men

A highly portable and rapid prostate cancer screening kit could provide early warning to populations with higher incidence of prostate cancer and particularly those with limited access to health care, such as African American ...

page 5 from 21